A052260 Stock Overview
HYUNDAI BIOLAND Co.,Ltd engages in the manufacture and sale of natural materials for cosmetics, nutraceuticals, and regenerative medicines worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 1/6 |
HYUNDAI BIOLAND Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩9,020.00 |
| 52 Week High | ₩13,740.00 |
| 52 Week Low | ₩8,430.00 |
| Beta | 0.51 |
| 1 Month Change | -0.11% |
| 3 Month Change | -8.98% |
| 1 Year Change | -26.79% |
| 3 Year Change | -60.26% |
| 5 Year Change | -48.60% |
| Change since IPO | 157.71% |
Recent News & Updates
Recent updates
Impressive Earnings May Not Tell The Whole Story For HYUNDAI BIOLANDLtd (KOSDAQ:052260)
Mar 19
Should You Buy HYUNDAI BIOLAND Co.,Ltd (KOSDAQ:052260) For Its Dividend?
Apr 12HYUNDAI BIOLAND Co.,Ltd's (KOSDAQ:052260) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?
Mar 08Update: HYUNDAI BIOLANDLtd (KOSDAQ:052260) Stock Gained 14% In The Last Five Years
Feb 15The Returns At HYUNDAI BIOLANDLtd (KOSDAQ:052260) Provide Us With Signs Of What's To Come
Jan 28Tread With Caution Around HYUNDAI BIOLAND Co.,Ltd's (KOSDAQ:052260) 1.5% Dividend Yield
Jan 10HYUNDAI BIOLANDLtd (KOSDAQ:052260) Takes On Some Risk With Its Use Of Debt
Dec 23Are Poor Financial Prospects Dragging Down HYUNDAI BIOLAND Co.,Ltd (KOSDAQ:052260 Stock?
Dec 05
The HYUNDAI BIOLANDLtd (KOSDAQ:052260) Share Price Is Up 55% And Shareholders Are Holding On
Nov 17Shareholder Returns
| A052260 | KR Personal Products | KR Market | |
|---|---|---|---|
| 7D | 2.9% | 1.8% | 3.4% |
| 1Y | -26.8% | -1.7% | 7.1% |
Return vs Industry: A052260 underperformed the KR Personal Products industry which returned -1.7% over the past year.
Return vs Market: A052260 underperformed the KR Market which returned 7.1% over the past year.
Price Volatility
| A052260 volatility | |
|---|---|
| A052260 Average Weekly Movement | 3.1% |
| Personal Products Industry Average Movement | 5.3% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.8% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A052260 has not had significant price volatility in the past 3 months.
Volatility Over Time: A052260's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | n/a | Chan-Bok Jeong | www.hyundaibioland.co.kr |
HYUNDAI BIOLAND Co.,Ltd engages in the manufacture and sale of natural materials for cosmetics, nutraceuticals, and regenerative medicines worldwide. The company’s cosmetics includes whitening, skin protection, moisturizing, anti-aging, sheet mask, and hair and body care products; and functional food ingredients comprising various nutraceuticals and general food raw ingredients. It is also involved in the provision of medical biomedical materials for dental, wound, orthopedic, and biomaterial applications; and manufacture and supply of active pharmaceutical ingredients from herbal medicines, such as artemisiae argyi herba, corydalis tuber and pharbitis seed, and magnolia bark, for domestic pharmaceutical companies.
HYUNDAI BIOLAND Co.,Ltd. Fundamentals Summary
| A052260 fundamental statistics | |
|---|---|
| Market cap | ₩135.30b |
| Earnings (TTM) | ₩8.06b |
| Revenue (TTM) | ₩101.69b |
16.8x
P/E Ratio1.3x
P/S RatioIs A052260 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A052260 income statement (TTM) | |
|---|---|
| Revenue | ₩101.69b |
| Cost of Revenue | ₩65.32b |
| Gross Profit | ₩36.37b |
| Other Expenses | ₩28.32b |
| Earnings | ₩8.06b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 537.08 |
| Gross Margin | 35.77% |
| Net Profit Margin | 7.92% |
| Debt/Equity Ratio | 23.7% |
How did A052260 perform over the long term?
See historical performance and comparison